There is evidence from Wang et al. that CXCL5 which is upregulated through YAP, can attract MDCSs (myeloid-derived suppressor cells) to the tumor by heterotypic CXCL5 binding to CXCR2 receptors [17]. The gene discussed is YAP1; the disease is neoplasm.